Francois-Thomas Mich (@ftmichaud) profile picture

CEO / Feldan: company enabling full potential in cell therapy

Québec, Canada
Joined September 2010
If a company wanted to deliver a gene therapy to the lung or liver, where the organ’s “surface area is huge,” the current price could be as much as $3 million per patient lnkd.in/dXKSvcJ
Feldan Therapeutics Announces Issuance of First Patent for its Peptide-Based Protein Delivery lnkd.in/du8BSvh
Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular lnkd.in/dg9MqM2
Lisez l’histoire fascinante de F.-T. Michaud, diplômé de génie chimique, et de l’entreprise @feldan_com. #diplôméUL bit.ly/2lAEIgf
1
1
Editas breathes sigh of relief as CRISPR ruling handed down lnkd.in/dyDTRdD
Dramatic twists could upend patent battle over CRISPR genome-editing method lnkd.in/ewQaNSG
Francois-Thomas Mich retweeted
@NovateurBio is Delighted to be #RESIBOS16 together with our valued client @feldan_com
2
3
CRISPR cuts out $90M IPO bid as another gene editing biotech goes public lnkd.in/eHkhkbc
Feldan will attend RESI in Boston - Feldan lnkd.in/eqquuyg
Feldan's poster presented at ASGCT 2016 last month! - Feldan lnkd.in/eFjrf3D
Feldan's poster presented at ASGCT 2016 last month! - Feldan lnkd.in/eFjrf3D
1
5
Feldan Animal-Free Cas9 protein now available! lnkd.in/e8wNGXB
1
| FRQS | CRISPR-Cas9 : Un traitement potentiel pour les maladies hérédit... lnkd.in/e6bWNHN
1
1